Skip to content
101010MIAMIAMIA

Drawing based on the label description. No photo yet.

“10 mg:, . Peach, round tablet, double scored on one side and debossed "10" over "MIA" on the other side”

10 MIA pill

Pill with imprint 10 MIA is orange, round, 8 mm and has been identified as Dextroamphetamine Sulfate 10 mg. It is used for ADHD and narcolepsy. It is supplied by Wilshire Pharmaceuticals, Inc.

Controlled substance: Schedule II

Dextroamphetamine Sulfate 10 mg

Imprint
10 MIA
Strength
10 mg
Used for
ADHD and narcolepsy
Color
Orange
Shape
Round
Size
8 mm
Score
Breaks into 4 pieces
Form
Tablet
Manufacturer
Wilshire Pharmaceuticals, Inc
Drug class
Stimulant (ADHD medicine)
NDC
52536-510, 52536-510-03, 52536-510-01, 24338-853, 24338-853-03, 72162-2350, 72162-2350-3

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Dextroamphetamine Sulfate pills and guides

What is Dextroamphetamine Sulfate used for?

Dextroamphetamine Sulfate is used for ADHD and narcolepsy.

Medicine type
Stimulant (ADHD medicine)
Official uses from the US prescribing label

Dextroamphetamine sulfate extended-release capsules are indicated in:

Narcolepsy

Attention Deficit Disorder with Hyperactivity

As an integral part of a total treatment program that typically includes other measures (psychological, educational, social) for patients (ages 6 years to 16 years) with this syndrome. A diagnosis of Attention Deficit Hyperactivity Disorder (ADHD; DSM-IV) implies the presence of the hyperactive-impulsive or inattentive symptoms that caused impairment and were present before age 7 years. The symptoms must cause clinically significant impairment, e.g., in social, academic, or occupational functioning, and be present in 2 or more settings, e.g., school (or work) and at home. The symptoms must not be better accounted for by another mental disorder. For the Inattentive Type, at least 6 of the following symptoms must have persisted for at least 6 months: lack of attention to details/careless mistakes; lack of sustained attention; poor listener; failure to follow through on tasks; poor organization; avoids tasks requiring sustained mental effort; loses things; easily distracted; forgetful. For the Hyperactive-Impulsive Type, at least 6 of the following symptoms must have persisted for at least 6 months: fidgeting/squirming; leaving seat; inappropriate running/climbing; difficulty with quiet activities; “on the go”; excessive talking; blurting answers; can’t wait turn; intrusive. The Combined Type requires both inattentive and hyperactive-impulsive criteria to be met.

Special Diagnostic Considerations

Specific etiology of this syndrome is unknown, and there is no single diagnostic test. Adequate diagnosis requires the use of medical and special psychological, educational, and social resources. Learning may or may not be impaired. The diagnosis must be based upon a complete history and evaluation of the patient and not solely on the presences of the required number of DSM-IV characteristics.

Need for Comprehensive Treatment Program

Dextroamphetamine sulfate extended-release is indicated as an integral part of a total treatment program for ADHD that may include other measures (psychological, educational, social) for patients with this syndrome. Drug treatment may not be indicated for all patients with this syndrome. Stimulants are not intended for use in patients who exhibit symptoms secondary to environmental factors and/or other primary psychiatric disorders, including psychosis. Appropriate educational placement is essential and psychosocial intervention is often helpful. When remedial measures alone are insufficient, the decision to prescribe stimulant medication will depend upon the physician’s assessment of the chronicity and severity of the patient’s symptoms.

Limitations of Use The use of dextroamphetamine sulfate extended-release capsules is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage.

From the FDA-approved label on DailyMed (published Oct 02, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows 10 MIA and the other side has only a score line.
  • It is orange, round, 8 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Dextroamphetamine Sulfate

Inactive: Silicon Dioxide, Crospovidone (120 .mu.m), Microcrystalline Cellulose, Stearic Acid, Fd&c Red No. 40, Fd&c Yellow No. 6, Fd&c Blue No. 2

Also distributed by

Azurity Pharmaceuticals, Inc., Bryant Ranch Prepack

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Dextroamphetamine Sulfate pills